CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 136 filers reported holding CASTLE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,873,075 | -51.7% | 258,498 | -50.0% | 0.12% | -50.8% |
Q4 2022 | $12,170,062 | -9.7% | 516,995 | 0.0% | 0.25% | -20.3% |
Q3 2022 | $13,483,000 | -32.8% | 516,995 | -43.4% | 0.31% | -40.0% |
Q2 2022 | $20,058,000 | -10.0% | 913,789 | +84.0% | 0.52% | +12.4% |
Q1 2022 | $22,281,000 | -13.2% | 496,675 | -17.1% | 0.46% | +22.9% |
Q4 2021 | $25,680,000 | -35.5% | 599,009 | 0.0% | 0.38% | -37.6% |
Q3 2021 | $39,834,000 | -32.0% | 599,009 | -25.0% | 0.60% | -32.0% |
Q2 2021 | $58,591,000 | +7.1% | 799,009 | 0.0% | 0.88% | +3.5% |
Q1 2021 | $54,700,000 | +2.0% | 799,009 | 0.0% | 0.85% | -5.1% |
Q4 2020 | $53,653,000 | +40.2% | 799,009 | +7.4% | 0.90% | -2.3% |
Q3 2020 | $38,260,000 | +26.3% | 743,642 | -7.5% | 0.92% | +8.1% |
Q2 2020 | $30,284,000 | +45.5% | 803,510 | +15.1% | 0.85% | -4.9% |
Q1 2020 | $20,811,000 | -4.1% | 698,118 | +10.6% | 0.90% | +9.5% |
Q4 2019 | $21,690,000 | +60.9% | 631,072 | -15.3% | 0.82% | +2.0% |
Q3 2019 | $13,478,000 | – | 745,045 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |